Boyu Su

1.1k total citations · 1 hit paper
22 papers, 620 citations indexed

About

Boyu Su is a scholar working on Biomedical Engineering, Oncology and Immunology. According to data from OpenAlex, Boyu Su has authored 22 papers receiving a total of 620 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Biomedical Engineering, 8 papers in Oncology and 7 papers in Immunology. Recurrent topics in Boyu Su's work include Nanoplatforms for cancer theranostics (11 papers), Immune cells in cancer (6 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Boyu Su is often cited by papers focused on Nanoplatforms for cancer theranostics (11 papers), Immune cells in cancer (6 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Boyu Su collaborates with scholars based in China, South Korea and Portugal. Boyu Su's co-authors include Chen Jiang, Tao Sun, Yifan Luo, Zhenhao Zhao, Yongchao Chu, Zheng Zhou, Peixin Liu, Qinjun Chen, Hongyi Chen and Lü Li and has published in prestigious journals such as Advanced Materials, Nano Letters and ACS Nano.

In The Last Decade

Boyu Su

19 papers receiving 617 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Engineered Bacterial Outer Membrane Vesicles‐Based Doxorubicin and CD47‐siRNA Co‐Delivery Nanoplatform Overcomes Immune Resistance to Potentiate the Immunotherapy of Glioblastoma

2025 21 citations Haoyu You, Shilin Zhang et al. Advanced Materials profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Boyu Su China	12	215	179	158	118	97	22	620
Kexin Shi China	10	160 0.7×	144 0.8×	75 0.5×	103 0.9×	52 0.5×	24	491
Kuoyang Sun China	10	199 0.9×	230 1.3×	168 1.1×	45 0.4×	26 0.3×	11	672
Abdulgader Baoum Saudi Arabia	13	109 0.5×	305 1.7×	104 0.7×	187 1.6×	91 0.9×	23	614
Henan Zhao China	11	406 1.9×	233 1.3×	353 2.2×	62 0.5×	61 0.6×	20	669
Jingwei Li China	14	80 0.4×	335 1.9×	128 0.8×	162 1.4×	185 1.9×	21	731
Daan Fu China	11	249 1.2×	174 1.0×	176 1.1×	155 1.3×	12 0.1×	22	684
Alevtina S. Semkina Russia	15	280 1.3×	161 0.9×	158 1.0×	278 2.4×	42 0.4×	45	649
Nengyi Ni Singapore	11	257 1.2×	119 0.7×	164 1.0×	125 1.1×	20 0.2×	20	429
Jingyi Peng China	16	132 0.6×	159 0.9×	166 1.1×	59 0.5×	19 0.2×	55	687
Veronica Vighetto Italy	13	263 1.2×	168 0.9×	163 1.0×	127 1.1×	21 0.2×	21	494

Countries citing papers authored by Boyu Su

Since Specialization

Citations

This map shows the geographic impact of Boyu Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boyu Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boyu Su more than expected).

Fields of papers citing papers by Boyu Su

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boyu Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boyu Su. The network helps show where Boyu Su may publish in the future.

Co-authorship network of co-authors of Boyu Su

This figure shows the co-authorship network connecting the top 25 collaborators of Boyu Su. A scholar is included among the top collaborators of Boyu Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boyu Su. Boyu Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Yu, Qinjun Chen, Haolin Song, et al.. (2025). Mitocytosis-inducing nanoparticles alleviate gemcitabine resistance via dual disruption of pyrimidine synthesis and redox homeostasis in pancreatic ductal adenocarcinoma. Biomaterials. 325. 123630–123630. 1 indexed citations

Zhou, Zheng, Haoyu You, Boyu Su, et al.. (2025). Multiple‐Stimuli‐Responsive Biomimetic Polypyrrole Delivery System for Synergistic Regulation and Restoration of Epileptic Foci. Advanced Functional Materials. 35(50).

You, Haoyu, Shilin Zhang, Yiwen Zhang, et al.. (2025). Engineered Bacterial Outer Membrane Vesicles‐Based Doxorubicin and CD47‐siRNA Co‐Delivery Nanoplatform Overcomes Immune Resistance to Potentiate the Immunotherapy of Glioblastoma. Advanced Materials. 37(15). e2418053–e2418053. 21 indexed citations breakdown →

Fang, Mingzhu, Boyu Su, Shilin Zhang, et al.. (2025). Engineered Intelligent Microenvironment Responsive Prodrug Conjugates Navigated by Bioinspired Lipoproteins for Reversing Liver Fibrosis. Small Methods. 9(7). e2402247–e2402247. 1 indexed citations

Zhang, Shilin, Haoyu You, Yun Chen, et al.. (2025). Transcytosis-Triggering Nanoparticles for Overcoming Stromal Barriers and Reversing Immunosuppression in Pancreatic Cancer Combinatorial Therapy. Nano Letters. 25(7). 2949–2959. 14 indexed citations

Li, Xu‐Wen, Shuo Geng, Qinjun Chen, et al.. (2025). Disrupting Tumor Lactate Homeostasis to Sensitize Chemo-Immunotherapy Using a Glucose-Disguised Lactate Interceptor. ACS Nano. 19(23). 21556–21570.

Li, Zhimeng, Yiyang Li, Chuan Wang, et al.. (2025). Engineered‐Macrophage‐Escorted Rotaxane Nanoscavengers for Precise Diquat Detoxification. Advanced Materials. 37(38). e2506466–e2506466.

Su, Boyu, Qinjun Chen, Xu‐Wen Li, et al.. (2025). A Methionine Allocation Nanoregulator for the Suppression of Cancer Stem Cells and Support to the Immune Cells by Epigenetic Regulation. Advanced Science. 12(15). e2415207–e2415207. 1 indexed citations

Su, Boyu, Shuo Geng, Davide Brambilla, et al.. (2024). Therapeutic regulation of epigenetics in cancer treatment through drug delivery systems. Nano Today. 56. 102251–102251. 7 indexed citations

10.

Song, Haolin, Hongyi Chen, Qinjun Chen, et al.. (2024). Size and Charge Dual‐Switchable Nanoparticles for Achieving Chemosensitization and Immune Infiltration against Pancreatic Ductal Adenocarcinoma. Advanced Functional Materials. 35(1). 2 indexed citations

11.

Li, Xuwen, Qin Guo, Qinjun Chen, et al.. (2024). Reconciling the Cooperative–Competitive Patterns among Tumor and Immune Cells for Triple‐Negative Breast Cancer Treatment Using Multimodule Nanocomplexes. Advanced Materials. 36(26). e2312219–e2312219. 16 indexed citations

12.

Chu, Yongchao, Boyu Su, Yifan Luo, et al.. (2023). Compound Nanoemulsion Combined with Differentiation/Cytotoxicity Drugs for Modulating Breast Cancer Stemness. Molecular Pharmaceutics. 20(3). 1591–1598. 3 indexed citations

13.

Zhao, Zhenhao, Chufeng Li, Yiwen Zhang, et al.. (2023). Nanomaterials with dual immunomodulatory functions for synergistic therapy of breast cancer brain metastases. Bioactive Materials. 27. 474–487. 12 indexed citations

14.

Chu, Yongchao, Yifan Luo, Boyu Su, et al.. (2022). A neutrophil-biomimic platform for eradicating metastatic breast cancer stem-like cells by redox microenvironment modulation and hypoxia-triggered differentiation therapy. Acta Pharmaceutica Sinica B. 13(1). 298–314. 34 indexed citations

15.

Chen, Hongyi, Qin Guo, Yongchao Chu, et al.. (2022). Smart hypoxia-responsive transformable and charge-reversible nanoparticles for the deep penetration and tumor microenvironment modulation of pancreatic cancer. Biomaterials. 287. 121599–121599. 61 indexed citations

16.

Chen, Qinjun, Qingbing Wang, Yu Wang, et al.. (2022). Penetrating Micelle for Reversing Immunosuppression and Drug Resistance in Pancreatic Cancer Treatment. Small. 18(18). e2107712–e2107712. 23 indexed citations

17.

Liu, Peixin, Tongyu Zhang, Qinjun Chen, et al.. (2021). Biomimetic Dendrimer–Peptide Conjugates for Early Multi‐Target Therapy of Alzheimer's Disease by Inflammatory Microenvironment Modulation. Advanced Materials. 33(26). e2100746–e2100746. 115 indexed citations

18.

Sun, Tao, Guang‐Ping Zhang, Tingting Ning, et al.. (2021). A Versatile Theranostic Platform for Colorectal Cancer Peritoneal Metastases: Real‐Time Tumor‐Tracking and Photothermal‐Enhanced Chemotherapy. Advanced Science. 8(20). e2102256–e2102256. 25 indexed citations

19.

Guo, Qin, Xuwen Li, Wenxi Zhou, et al.. (2021). Sequentially Triggered Bacterial Outer Membrane Vesicles for Macrophage Metabolism Modulation and Tumor Metastasis Suppression. ACS Nano. 15(8). 13826–13838. 113 indexed citations

20.

Wang, Dezhi, Boyu Su, Yan Jiang, et al.. (2017). Polytype 1T/2H MoS2 heterostructures for efficient photoelectrocatalytic hydrogen evolution. Chemical Engineering Journal. 330. 102–108. 130 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact